A Standardized Cardiac Protocol for Pediatric Drug Ingestion Hospital Admissions

Erica L Del Grippo1, Shankar Baskar2, Seth Gray2

  • 1Nemours Cardiac Center, AI duPont Hospital for Children, Wilmington, Del.

Insights

A new guideline for pediatric drug ingestions safely reduced hospital admissions for telemetry monitoring by 87%. This improved patient resource utilization without increasing adverse events.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Toxicology
  • Cardiology

Background:

  • Hospital admissions for pediatric drug ingestions require careful resource allocation and patient monitoring.
  • Standardized guidelines are essential for optimizing care and safety in these cases.

Purpose of the Study:

  • To develop and implement a standard-of-care guideline for pediatric drug ingestion hospital admissions.
  • To optimize patient resource utilization and safety through a new admission protocol.

Main Methods:

  • A multidisciplinary committee established telemetry monitoring guidelines for pediatric drug ingestions based on specific criteria (QTc interval, antiarrhythmic or tricyclic antidepressant ingestion).
  • Guidelines for electrocardiogram frequency were created for non-telemetry admissions.
  • Medical records from January 2015 to July 2016 were reviewed, comparing pre- and post-intervention periods using statistical process control charts.

Main Results:

  • The study included 622 pediatric drug ingestion admissions.
  • Post-implementation, cardiac acute care unit (CACU) admissions for telemetry monitoring decreased by 87% (from 5.5 to 1.1 per month).
  • No increase in intensive care unit utilization, rapid response events, or adverse events was observed.

Conclusions:

  • A standardized admission protocol for pediatric drug ingestions effectively improves resource utilization.
  • The implemented guidelines safely reduced unnecessary telemetry monitoring admissions.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
195
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
160
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
465
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
874
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
186
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
205